|
via Udemy |
Go to Course: https://www.udemy.com/course/technical-project-management-for-generic-drug-development/
I recently completed the Coursera course titled "Technical Project Management for Generic Drug Development," and I highly recommend it for professionals and students interested in the pharmaceutical industry, especially those focusing on generic drug development. This comprehensive course offers an in-depth overview of the key aspects involved in managing complex pharmaceutical projects. Course Content and Structure: The course is structured into detailed modules covering everything from the fundamentals of generic drug development to advanced project management techniques. It starts with an introduction to the pharmaceutical industry, including the differences between Active Pharmaceutical Ingredients (API) and finished pharmaceutical products, as well as the important concepts of bioequivalency and reference listed drugs (RLD). Subsequently, it delves into project management principles, including project lifecycle, stakeholder management, and essential tools like Gantt charts and project diaries, tailored specifically for generic drug projects. The course also emphasizes desk research methodologies, providing insights into regulatory agencies such as EMA, FDA, and WHO, along with valuable resources like DrugBank and Espacenet. One of the most impressive features is the detailed guidance on the stages of drug development, from raw material selection, pre-formulation studies, and analytical method development to formulation, validation, and pilot manufacturing. The course culminates with stages on bioequivalency studies, registration dossiers, and project conclusion, making it a complete roadmap for managing generic drug projects. Review and Strengths: The course materials are well-organized and up-to-date, offering valuable practical insights alongside theoretical knowledge. The inclusion of multiple case studies and real-world examples enhances learning and applicability. The instructors communicate complex topics clearly, making it accessible even for learners new to pharmaceutical project management. Moreover, the focus on project management tools specifically designed for the pharmaceutical context is extremely beneficial for those aiming to lead or participate in these projects. The modules on regulatory documentation and registration processes are particularly crucial for ensuring compliance and successful market entry. Recommendation: Whether you are a project manager, a scientist, or a student aspiring to enter the pharmaceutical industry, this course provides essential knowledge and skills to effectively oversee generic drug development projects. It bridges the gap between pharmaceutical sciences and project management, empowering learners to handle complex projects with confidence. In conclusion, I highly recommend "Technical Project Management for Generic Drug Development" on Coursera for anyone looking to enhance their expertise in this vital field. Its comprehensive content, practical approach, and industry-specific focus make it an invaluable resource for advancing your career or academic pursuits in pharmaceutical R&D and project management. --- If you'd like, I can help you with additional insights on specific modules, how to apply this knowledge in real projects, or tips for succeeding in similar courses.
COURSE CONTENT 1 Introduction 2 Introduction to Generic Drug Development 2.1. Active Pharmaceutical Ingredient (API) & Finished Pharmaceutical Product (FPP) 2.2. Reference Listed Drug (RLD) & Generic (Multisource) Pharmaceutical Products 2.3. Pharmaceutical Bioequivalency (Therapeutic Equivalency) 2.4. Reference Listed Drug (RLD) Development 2.5. Generic Drug Development 2.6. Comparision of Reference Listed Drug (RLD) Development & Generic Drug Development 2.7. In-vitro & In-vivo Studies for Drug Product 3 Introduction to Project Management 3.1. Project & Elements of Project (Cost, Time, Scope) 3.2. Priorizitation of Project (Pipeline) 3.3. Project Phases 3.4. Project Manager 3.5. Project Team & Project Stakeholders 3.6. Project Management Tools 4 Project Management for Generic Drug Development 4.1. Project Diary for Generic Drug Development 4.2. Project Milestones for Generic Drug Development 4.3. Project Gantt Chart for Generic Drug Development 4.4. Generic Drug Development Project Phases (Execution Phase) 5 Desk Research for Generic Drug Development 5.1. Desk Research for Generic Drug Development 5.2. European Medicines Agency (EMA) 5.3. World Health Organization (WHO) & Food and Drug Administration (FDA) 5.4. Pharmacopoeias & Dailymed 5.5. Drugscom 5.6. DrugBank 5.7. Google Patents 5.8. Espacenet 6 Raw Material Selection for Generic Drug Development 6.1. Raw Material Selection for Generic Drug Development 6.2. Evaluation of Characteristics of API 6.3. Evaluation of Stability Characteristics of API 6.4. Evaluation of Suppliers of API 6.5. Evaluation of Inactive Ingredient and Packaging Material 7 Pre-Formulation Studies for Generic Drug Development 7.1. Pre-Formulation Studies for Generic Drug Development 7.2. Characterization of RLD 7.3. Defining Quality Target Product Profile (QTPP) 7.4. Evaluation of BE Requirements 7.5. Evaluation of Inactive Ingredient Required for Formula 7.6. Compatibility Study 7.7. Supplying New material / Apparatus / Equipment 7.8. Performing Pre-Formulation Trials 8 Analytical Method Development Studies for Generic Drug Development 8.1. Analytical Method Development Studies for Generic Drug Development-1 8.2. Analytical Method Development Studies for Generic Drug Development-2 8.3. Literature Search for Analytical Method Development 8.4. Supplying Chemicals / Materials / Equipments 8.5. Performing Method Development Studies 8.6. Determining Acceptance Criteria 8.7. Determining Dissolution Parameters 8.8. Performing Stress Studies 8.9. Performing Pre-Validation Studies 9 Formulation Studies for Generic Drug Development 9.1. Formulation Studies for Generic Drug Development 9.2. Performing Formulation Trials 9.3. Optimizing Formulation by using QBD 9.4. Supplying Chemicals / Raw-Materials / Equipments for Pilot Manufacturing 9.5. Preparing Formulations for Critical Material Attributes (CMA) 9.6. Preparing Formulations for Critical Quality Attribute (CQA) 9.7. Preparing Formulations for Critical Process Parameter (CPP) 9.8. Discriminitive Dissolution Parameters 9.9. Compatibility Study with Final Formula / Components 10 Analytical Studies for Generic Drug Development 10.1. Validation of Analytical Methods 10.2. Evaluation Bulk and Product Characteristic / Performance 10.3. Comparision Test Product with RLD In-vitro Conditions 10.4. Performing Analysis of Formulations for Critical Material Attributes (CMA) 10.5. Performing Analysis of Formulations for Critical Quality Attribute (CQA) 10.6. Performing Analysis of Formulations for Critical Process Parameter (CPP) 10.7. Performing Analysis of Formulations for for Discrimitive Dissolution Parameters 10.8. Performing Analysis of Formulations for Compatibility Study with Final Formula / Components 11 Pilot Manufacturing for Generic Drug Development 11.1. Evaluation of Chemicals / Raw-materials / Equipments used for Pilot Manufacturing 11.2. Performing Risk Assesment for Pilot Manufacturing 11.3. Performing Quality Procedures for Pilot Manufacturing 11.4. Documentation for Pilot Manufacturing 11.5. Manufacturing of Pilot Batches 12 Analysis of Pilot Batches for Generic Drug Development 12.1. Analysis of Chemicals / Raw-Materials used for Pilot Manufacturing 12.2. Analysis of Pilot Batches 12.3. Comparision Pilot Batches with RLD in In-vitro Conditions 12.4. Determining of BE Batches 13 Performing Bioequivalency Study for Generic Drug Development 13.1. Preparing Documentation for In-vitro Test Results 13.2. Preparation of Samples for BE Studies 13.3. Performing BE Studies 13.4. Documentating of BE Results 14 Preparation Registration Dossier for Generic Drug Development 14.1. Preparation of Registration Dossier 14.2. Performing of Registration Application 15 Conclusion